Connecticut House Bill HB05732

Connecticut 2017 Regular Session

• Introduced: 1/17/17
• Refer: 1/17/17

Caption

An Act Concerning The Labeling Of Prescription Drug Containers Containing Opiates.

Impact

If implemented, HB 05732 would amend existing general statutes pertaining to the labeling of prescription drugs. This change is meant to provide patients with clearer information on the medications they are prescribed, particularly focusing on the effects and dangers of consuming opiates. By highlighting the heroin rating, the bill aims to raise awareness among patients about the severity of the drugs they are handling, potentially impacting physician practices and patient compliance with medication prescriptions.

Summary

House Bill 05732 aims to enhance patient awareness regarding prescription opiate drugs by mandating specific labeling requirements for containers of these medications. The bill proposes that each prescription container containing an opiate must include a heroin rating, which is intended to inform patients about the drug's potency and the potential negative consequences associated with its use. The rationale behind this legislative effort stems from rising concerns about opioid abuse and the broader opioid crisis affecting many communities.

Contention

There could be a variety of perspectives on HB 05732. Proponents might argue that the bill serves an essential public health function by arming patients with the knowledge necessary to make informed decisions about their medications. However, some critics could contend that the added labeling may lead to undue fear or stigma associated with necessary pain management treatments. Additionally, concerns may arise regarding the feasibility of implementing these labeling changes within the pharmaceutical industry and pharmacies, particularly if it imposes additional burdens on healthcare providers and facilities.